Jenny A. Visser
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jenny A. Visser has a total of 471 co-authors. Here are the top co-authors by number of shared publications:
Anke McLuskey
University Medical Center
6 shared publications- Erica L. T. van Den Akker
Erasmus University Medical Center, Rotterdam, The Netherlands
6 shared publications Jacobie Steenbergen
University Medical Center
6 shared publications- Joop Stephanus Elisabeth Laven
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynaecology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands
6 shared publications - Yvonne V. Louwers
Department of Obstetrics and Gynecology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands
6 shared publications Aldo Grefhorst
Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
5 shared publications
Latest Publications
- 5 November 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
Reproductive factors in women with familial hypercholesterolaemia
Aims: Hypercholesterolaemia has been associated with earlier menarche and menopause; however, these observations may reflect reverse causation or confounding. Familial Hypercholesterolaemia (FH) provides a model to investigate these associations. This study compared reproductive characteristics and pregnancy outcomes in women with FH vs. women without FH. Methods and results: Between November 2023 and April 2025, women with FH aged ≥40 years were recruited from two university hospital outpatient clinics in the Netherlands and Norway. Women without FH were selected from the Rotterdam Study and Norwegian population-based cohorts. FH cases were matched 1:2 to women without FH on age, smoking status, body mass index, and ethnicity using nearest-neighbour matching. Information on reproductive factors and pregnancy outcomes were obtained via an online survey. 484 women with FH and 968 matched women without FH (median age 55 years [IQR 48–62]; 93% North-Western European) were included. Cardiovascular disease prevalence was higher in women with FH (22% vs. 4%; P < 0.001). Most women with FH (95%) used lipid-lowering therapy, LDL cholesterol levels were lower compared to controls (2.5 vs. 3.5 mmol/L; P < 0.001). Women with FH more often had been pregnant (91% vs. 84%; P < 0.001). Prevalence of gestational diabetes (4% vs. 4%; P = 0.70) and hypertensive disorders of pregnancy (16% vs. 13%; P = 0.10) was similar; however, preeclampsia was more frequent in FH (11% vs. 7%; P = 0.030). Age at menarche (13.2 vs. 13.1 years; P = 0.43), age at menopause (50 years; P = 0.92), and reproductive lifespan (36 years; P = 0.98) were similar between groups. Conclusion: Reproductive lifespan is comparable between women with and without FH, but FH was associated with a higher prevalence of preeclampsia, highlighting the importance of targeted pregnancy monitoring and prevention.
- 5 November 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
Reproductive factors in women with familial hypercholesterolaemia
Aims: Hypercholesterolaemia has been associated with earlier menarche and menopause; however, these observations may reflect reverse causation or confounding. Familial Hypercholesterolaemia (FH) provides a model to investigate these associations. This study compared reproductive characteristics and pregnancy outcomes in women with FH vs. women without FH. Methods and results: Between November 2023 and April 2025, women with FH aged ≥40 years were recruited from two university hospital outpatient clinics in the Netherlands and Norway. Women without FH were selected from the Rotterdam Study and Norwegian population-based cohorts. FH cases were matched 1:2 to women without FH on age, smoking status, body mass index, and ethnicity using nearest-neighbour matching. Information on reproductive factors and pregnancy outcomes were obtained via an online survey. 484 women with FH and 968 matched women without FH (median age 55 years [IQR 48–62]; 93% North-Western European) were included. Cardiovascular disease prevalence was higher in women with FH (22% vs. 4%; P < 0.001). Most women with FH (95%) used lipid-lowering therapy, LDL cholesterol levels were lower compared to controls (2.5 vs. 3.5 mmol/L; P < 0.001). Women with FH more often had been pregnant (91% vs. 84%; P < 0.001). Prevalence of gestational diabetes (4% vs. 4%; P = 0.70) and hypertensive disorders of pregnancy (16% vs. 13%; P = 0.10) was similar; however, preeclampsia was more frequent in FH (11% vs. 7%; P = 0.030). Age at menarche (13.2 vs. 13.1 years; P = 0.43), age at menopause (50 years; P = 0.92), and reproductive lifespan (36 years; P = 0.98) were similar between groups. Conclusion: Reproductive lifespan is comparable between women with and without FH, but FH was associated with a higher prevalence of preeclampsia, highlighting the importance of targeted pregnancy monitoring and prevention.
- Open Access
- 8 October 2026
- Published by Springer Nature in Metabologia
- Vol. 2 (1) , 18
Subcutaneous adipocyte glucocorticoid-responsive transcripts after modest weight gain in South Asian and White European men: an exploratory longitudinal study
Aims/hypothesis: Adipocyte glucocorticoid (GC)-responsive transcripts are linked to lipid storage and insulin sensitivity, and South Asians develop insulin resistance at lower BMI than White Europeans. We tested whether modest short-term weight gain was associated with adipocyte GC-related transcripts differently by ancestry and whether within-person transcript changes were associated with dynamic insulin responses. Methods: In this exploratory secondary analysis of the GlasVEGAS study, White European ( n = 21) and South Asian ( n = 14) men underwent ~ 6% diet-induced weight gain. Isolated abdominal subcutaneous adipocytes were sampled at baseline and post-weight gain for RT-qPCR assessment of GC-responsive transcripts and related targets. Metabolic responses were characterised using a standardised mixed-meal test with 5 h profiles of glucose, insulin, C-peptide and triglycerides; hepatic triacylglycerol content was quantified by MRI. Results: Weight gain reduced FKBP5 (− 23.65 ± 8.82% in White Europeans; − 17.68 ± 11.62% in South Asians; p = 0.007) and TSC22D3 (also known as GILZ ; − 11.40 ± 2.83%; − 5.95 ± 4.01%; p = 0.001 for change with weight gain), with no ethnicity × intervention interaction ( p ≥ 0.26). HSD11B1 / HSD11B2 and IL2 / IL6 did not change. At baseline, FKBP5 and GILZ were associated with adiposity, liver fat and adipocyte size. Within-person Δ FKBP5 (post-weight gain minus baseline) correlated with Δpostprandial insulin ( r = 0.46, p = 0.006) and ΔC-peptide ( r = 0.34, p = 0.049). Δ GILZ correlated with Δfasting glucose ( r = − 0.40, p = 0.017) and Δpostprandial insulin ( r = 0.34, p = 0.049). In exploratory within-person analyses, changes in FKBP5 and GILZ were associated with changes in postprandial insulin-related measures. Conclusion/interpretation: Early modest weight gain downregulates adipocyte GC-responsive transcripts, with no statistically significant ethnicity-by-weight gain interaction detected in this modest-sized exploratory cohort, and dynamic transcript changes track insulin exposure. These findings implicate a potential link between dynamic insulin responses and adipocyte glucocorticoid-responsive transcription during early weight gain, linking adipocyte transcriptional responses to clinically relevant postprandial insulin physiology.
- 8 October 2026
- Published by Springer Nature in Metabologia
- Vol. 2 (1) , 18
Open AccessSubcutaneous adipocyte glucocorticoid-responsive transcripts after modest weight gain in South Asian and White European men: an exploratory longitudinal study
Aims/hypothesis: Adipocyte glucocorticoid (GC)-responsive transcripts are linked to lipid storage and insulin sensitivity, and South Asians develop insulin resistance at lower BMI than White Europeans. We tested whether modest short-term weight gain was associated with adipocyte GC-related transcripts differently by ancestry and whether within-person transcript changes were associated with dynamic insulin responses. Methods: In this exploratory secondary analysis of the GlasVEGAS study, White European ( n = 21) and South Asian ( n = 14) men underwent ~ 6% diet-induced weight gain. Isolated abdominal subcutaneous adipocytes were sampled at baseline and post-weight gain for RT-qPCR assessment of GC-responsive transcripts and related targets. Metabolic responses were characterised using a standardised mixed-meal test with 5 h profiles of glucose, insulin, C-peptide and triglycerides; hepatic triacylglycerol content was quantified by MRI. Results: Weight gain reduced FKBP5 (− 23.65 ± 8.82% in White Europeans; − 17.68 ± 11.62% in South Asians; p = 0.007) and TSC22D3 (also known as GILZ ; − 11.40 ± 2.83%; − 5.95 ± 4.01%; p = 0.001 for change with weight gain), with no ethnicity × intervention interaction ( p ≥ 0.26). HSD11B1 / HSD11B2 and IL2 / IL6 did not change. At baseline, FKBP5 and GILZ were associated with adiposity, liver fat and adipocyte size. Within-person Δ FKBP5 (post-weight gain minus baseline) correlated with Δpostprandial insulin ( r = 0.46, p = 0.006) and ΔC-peptide ( r = 0.34, p = 0.049). Δ GILZ correlated with Δfasting glucose ( r = − 0.40, p = 0.017) and Δpostprandial insulin ( r = 0.34, p = 0.049). In exploratory within-person analyses, changes in FKBP5 and GILZ were associated with changes in postprandial insulin-related measures. Conclusion/interpretation: Early modest weight gain downregulates adipocyte GC-responsive transcripts, with no statistically significant ethnicity-by-weight gain interaction detected in this modest-sized exploratory cohort, and dynamic transcript changes track insulin exposure. These findings implicate a potential link between dynamic insulin responses and adipocyte glucocorticoid-responsive transcription during early weight gain, linking adipocyte transcriptional responses to clinically relevant postprandial insulin physiology.
- 1 October 2026
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 331 (4) , E479-E490
Enhanced behavioral responses to ghrelin administration are unaffected by ghrelin deficiency in a DHT-induced PCOS mouse model
This study uniquely examined how ghrelin deficiency interacts with prepubertal chronic DHT exposure, a PMOS mouse model, shaping metabolism and eating behavior in female mice. Although ghrelin deficiency minimally altered DHT-induced reproductive or metabolic phenotypes, chronic DHT exposure affected behavioral responses to acute ghrelin, indicating interacting mechanisms between androgen and ghrelin signaling in PMOS. This work highlights the importance of detailed behavioral assessment of translational models of disease to explore mechanisms behind aberrant behavior.
- 1 October 2026
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 331 (4) , E479-E490
Enhanced behavioral responses to ghrelin administration are unaffected by ghrelin deficiency in a DHT-induced PCOS mouse model
This study uniquely examined how ghrelin deficiency interacts with prepubertal chronic DHT exposure, a PMOS mouse model, shaping metabolism and eating behavior in female mice. Although ghrelin deficiency minimally altered DHT-induced reproductive or metabolic phenotypes, chronic DHT exposure affected behavioral responses to acute ghrelin, indicating interacting mechanisms between androgen and ghrelin signaling in PMOS. This work highlights the importance of detailed behavioral assessment of translational models of disease to explore mechanisms behind aberrant behavior.
- Open Access
- 16 September 2026
- Published by The Endocrine Society in Endocrinology
- Vol. 167 (11)
Tagln1-Cre –driven Ercc1 deficiency reveals sex-specific effects on adipose tissue in mice
Metabolic aging is marked by changes in insulin sensitivity and adipose tissue remodeling, including the vasculature. Transgelin 1 (Tagln1), a marker for vascular smooth muscle cells (VSMC), is used as a promoter for Cre-driven gene knockout (KO) in mice. However, Tagln1 is also expressed in white adipocytes. We previously showed that Tagln1-Cre–driven KO of DNA repair endonuclease Ercc1 in mice (Tagln1-Cre Ercc1 mice) leads to accelerated aging of VSMC and perivascular adipocytes, resulting in vascular dysfunction and lipodystrophic-like perivascular adipose tissue. The aim of this study was to investigate the consequences of Tagln1-driven Ercc1 deficiency on whole-body metabolism and adipose tissue morphology and function. Tagln1-Cre Ercc1 mice did not show the usual age-related gain in fat mass. Adipose tissue depots from male Tagln1-Cre Ercc1 mice shared similarities with adipose tissue depots from advanced-aged mice, including smaller white adipocyte size, decreased vascularization, increased oxidative stress, macrophage infiltration, and fibrosis compared with male wild-type (WT) mice. Female Tagln1-Cre Ercc1 mice showed an upregulation of antioxidant genes, which might be a protective response resulting in minor changes in their adipose tissue depots compared with female WT mice. Male Tagln1-Cre Ercc1 mice showed partially preserved adipose tissue function and improved insulin sensitivity. Interestingly, analyses showed that Tagln1 expression varied by sex and adipose tissue depot in WT mice. To conclude, we showed that accelerated aging induced by Ercc1 deficiency in Tagln1-dependent cell populations leads to white adipose tissue and brown adipose tissue remodeling and inflammation, as also observed in normal aging
- 16 September 2026
- Published by The Endocrine Society in Endocrinology
- Vol. 167 (11)
Open AccessTagln1-Cre –driven Ercc1 deficiency reveals sex-specific effects on adipose tissue in mice
Metabolic aging is marked by changes in insulin sensitivity and adipose tissue remodeling, including the vasculature. Transgelin 1 (Tagln1), a marker for vascular smooth muscle cells (VSMC), is used as a promoter for Cre-driven gene knockout (KO) in mice. However, Tagln1 is also expressed in white adipocytes. We previously showed that Tagln1-Cre–driven KO of DNA repair endonuclease Ercc1 in mice (Tagln1-Cre Ercc1 mice) leads to accelerated aging of VSMC and perivascular adipocytes, resulting in vascular dysfunction and lipodystrophic-like perivascular adipose tissue. The aim of this study was to investigate the consequences of Tagln1-driven Ercc1 deficiency on whole-body metabolism and adipose tissue morphology and function. Tagln1-Cre Ercc1 mice did not show the usual age-related gain in fat mass. Adipose tissue depots from male Tagln1-Cre Ercc1 mice shared similarities with adipose tissue depots from advanced-aged mice, including smaller white adipocyte size, decreased vascularization, increased oxidative stress, macrophage infiltration, and fibrosis compared with male wild-type (WT) mice. Female Tagln1-Cre Ercc1 mice showed an upregulation of antioxidant genes, which might be a protective response resulting in minor changes in their adipose tissue depots compared with female WT mice. Male Tagln1-Cre Ercc1 mice showed partially preserved adipose tissue function and improved insulin sensitivity. Interestingly, analyses showed that Tagln1 expression varied by sex and adipose tissue depot in WT mice. To conclude, we showed that accelerated aging induced by Ercc1 deficiency in Tagln1-dependent cell populations leads to white adipose tissue and brown adipose tissue remodeling and inflammation, as also observed in normal aging
- Top Cited PapersOpen Access
- 23 April 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (5) , 1040-1050
Genomic analyses implicate hormonal and metabolic dysregulation in polycystic ovary syndrome
Polycystic ovary syndrome (PCOS) and its underlying features remain poorly understood. In this genetic study ( n = 544,513), we expand the number of genetic loci from 16 to 29, and additionally identify 31 associated plasma proteins. Many risk-increasing loci were associated with later age at menopause, underscoring the reproductive longevity related to an increased oocyte number and/or availability across the lifespan. Hormonal regulation in the etiology of this condition, through metabolic and reproductive features, was emphasized. The proteomic analysis highlighted metabolic biology known to be related to PCOS. A polygenic risk score (PRS) was associated with adverse cardiometabolic outcomes, with differing relevance of testosterone and body mass index in women and men. Finally, while oligo-anovulation and anovulatory infertility are features of PCOS, we observed no impact of PCOS susceptibility on childlessness. We suggest that PCOS susceptibility confers balanced pleiotropic influences on fertility in women, and life-long adverse metabolic consequences in both sexes.
- 23 April 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (5) , 1040-1050
Top Cited PapersOpen AccessGenomic analyses implicate hormonal and metabolic dysregulation in polycystic ovary syndrome
Polycystic ovary syndrome (PCOS) and its underlying features remain poorly understood. In this genetic study ( n = 544,513), we expand the number of genetic loci from 16 to 29, and additionally identify 31 associated plasma proteins. Many risk-increasing loci were associated with later age at menopause, underscoring the reproductive longevity related to an increased oocyte number and/or availability across the lifespan. Hormonal regulation in the etiology of this condition, through metabolic and reproductive features, was emphasized. The proteomic analysis highlighted metabolic biology known to be related to PCOS. A polygenic risk score (PRS) was associated with adverse cardiometabolic outcomes, with differing relevance of testosterone and body mass index in women and men. Finally, while oligo-anovulation and anovulatory infertility are features of PCOS, we observed no impact of PCOS susceptibility on childlessness. We suggest that PCOS susceptibility confers balanced pleiotropic influences on fertility in women, and life-long adverse metabolic consequences in both sexes.
- Open Access
- 23 February 2026
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 35 (5)
Functional characterisation of obesity-associated MRAP2 variants on MC4R and GHSR signalling
Melanocortin-2 receptor accessory protein-2 (MRAP2) modulates the activity of hypothalamic melanocortin-4 (MC4R) and growth hormone-secretagogue (GHSR) receptors, which suppress and promote appetite, respectively. We investigate whether obesity-associated variants of MRAP2 alter their ability to modulate MC4R and GHSR signalling as a possible mechanistic link to the development of obesity. Functional effects of five obesity-associated MRAP2 variants were analysed in HEK293 cells by co-expressing wild-type or variant MRAP2 with MC4R or GHSR. Endpoints included cell-surface and total expression, and ligand-induced second-messenger responses, β-arrestin-2 recruitment, and alternative G-protein activation. MRAP2 decreased basal MC4R cell-surface expression while GHSR cell-surface expression was not affected. In MC4R/MRAP2 expressing cells, maximal α-MSH-induced cAMP and β-arrestin-2 recruitment responses were increased. Similarly, ghrelin-induced Ca2+-mobilization in GHSR/MRAP2 expressing cells was increased, but β-arrestin-2 recruitment was suppressed. MRAP2 did not bias G-protein activation by either receptor, although previous reports show MRAP2 biases MC4R signalling towards Gαq/11. The variants did not significantly affect the ability of MRAP2 to modulate MC4R and GHSR signalling. Our results indicate that MRAP2 potentiates the ligand responsiveness of MC4R and GHSR, but has differential effects on β-arrestin-2 recruitment. The MRAP2 variants had no significant effects on the signalling endpoints tested. This suggests that, despite their association with obesity, the variants may be functionally benign, or that the absence of effects reflects limitations inherent to our cellular model. In addition, since MRAP2 can modulate multiple receptors and differentially modulate their signalling, we cannot rule out their influence on body weight regulation via other mechanisms.
- 23 February 2026
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 35 (5)
Open AccessFunctional characterisation of obesity-associated MRAP2 variants on MC4R and GHSR signalling
Melanocortin-2 receptor accessory protein-2 (MRAP2) modulates the activity of hypothalamic melanocortin-4 (MC4R) and growth hormone-secretagogue (GHSR) receptors, which suppress and promote appetite, respectively. We investigate whether obesity-associated variants of MRAP2 alter their ability to modulate MC4R and GHSR signalling as a possible mechanistic link to the development of obesity. Functional effects of five obesity-associated MRAP2 variants were analysed in HEK293 cells by co-expressing wild-type or variant MRAP2 with MC4R or GHSR. Endpoints included cell-surface and total expression, and ligand-induced second-messenger responses, β-arrestin-2 recruitment, and alternative G-protein activation. MRAP2 decreased basal MC4R cell-surface expression while GHSR cell-surface expression was not affected. In MC4R/MRAP2 expressing cells, maximal α-MSH-induced cAMP and β-arrestin-2 recruitment responses were increased. Similarly, ghrelin-induced Ca2+-mobilization in GHSR/MRAP2 expressing cells was increased, but β-arrestin-2 recruitment was suppressed. MRAP2 did not bias G-protein activation by either receptor, although previous reports show MRAP2 biases MC4R signalling towards Gαq/11. The variants did not significantly affect the ability of MRAP2 to modulate MC4R and GHSR signalling. Our results indicate that MRAP2 potentiates the ligand responsiveness of MC4R and GHSR, but has differential effects on β-arrestin-2 recruitment. The MRAP2 variants had no significant effects on the signalling endpoints tested. This suggests that, despite their association with obesity, the variants may be functionally benign, or that the absence of effects reflects limitations inherent to our cellular model. In addition, since MRAP2 can modulate multiple receptors and differentially modulate their signalling, we cannot rule out their influence on body weight regulation via other mechanisms.
- Open Access
The impact of immune checkpoint inhibitors on gonadal function in patients with solid tumors
- Open Access
- 15 November 2025
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (2) , e586-e602
Sex Differences in Leptin Levels in Children and Adolescents with Normal Weight and Overweight/Obesity Across Pubertal Stages: A Systematic Review and Meta-analysis
Context: Leptin levels differ significantly between adult men and women, it is unknown whether these sex differences arise during puberty in children with normal weight (NW) or overweight (OW)/obesity (OB). Objective: To analyze sex differences in leptin levels and body mass index SD score across pubertal stages in children with NW and OW/OB. Data Sources: Eligible studies were obtained from Medline, Embase, Web of Science, Cochrane, and CINAHL from inception until February 2025. Study Selection: Twenty-four of 1713 studies assessing leptin levels in children aged 5 to 19 years were included. Data Extraction: Two reviewers independently extracted data and assessed study quality. Data Synthesis: We performed subgroup meta-analysis stratified for pubertal stage using random effects model to estimate the weighted mean difference in R. Girls with NW had higher leptin levels than boys at all pubertal stages (pooled mean difference [MD]: 3.99; 95% CI, 2.63-5.35). In children with OW/OB, no significant differences were found in the prepubertal and pubertal stages. At the postpubertal stage, leptin levels were higher in girls compared to boys (MD: 14.60; 95% CI, 0.95-28.25), based on 1 included study. In pubertal children with OW/OB, body mass index SD score was higher in boys than girls (MD: −0.67; 95% CI, −0.74 to −0.61). Conclusion: The sex-specific differences in leptin levels, characteristic of normal-weight (pre-)pubertal children is lost in obesity. Therefore, leptin levels alone are unlikely to explain why obesity accelerates puberty in girls more than in boys. A combined effect with other factors, such as sex dimorphism in kisspeptin, may play a role.
- 15 November 2025
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (2) , e586-e602
Open AccessSex Differences in Leptin Levels in Children and Adolescents with Normal Weight and Overweight/Obesity Across Pubertal Stages: A Systematic Review and Meta-analysis
Context: Leptin levels differ significantly between adult men and women, it is unknown whether these sex differences arise during puberty in children with normal weight (NW) or overweight (OW)/obesity (OB). Objective: To analyze sex differences in leptin levels and body mass index SD score across pubertal stages in children with NW and OW/OB. Data Sources: Eligible studies were obtained from Medline, Embase, Web of Science, Cochrane, and CINAHL from inception until February 2025. Study Selection: Twenty-four of 1713 studies assessing leptin levels in children aged 5 to 19 years were included. Data Extraction: Two reviewers independently extracted data and assessed study quality. Data Synthesis: We performed subgroup meta-analysis stratified for pubertal stage using random effects model to estimate the weighted mean difference in R. Girls with NW had higher leptin levels than boys at all pubertal stages (pooled mean difference [MD]: 3.99; 95% CI, 2.63-5.35). In children with OW/OB, no significant differences were found in the prepubertal and pubertal stages. At the postpubertal stage, leptin levels were higher in girls compared to boys (MD: 14.60; 95% CI, 0.95-28.25), based on 1 included study. In pubertal children with OW/OB, body mass index SD score was higher in boys than girls (MD: −0.67; 95% CI, −0.74 to −0.61). Conclusion: The sex-specific differences in leptin levels, characteristic of normal-weight (pre-)pubertal children is lost in obesity. Therefore, leptin levels alone are unlikely to explain why obesity accelerates puberty in girls more than in boys. A combined effect with other factors, such as sex dimorphism in kisspeptin, may play a role.
- Open Access
- 6 November 2025
- Published by The Endocrine Society in Endocrinology
- Vol. 166 (12)
11- Oxygenated Androgens Inhibit Brown Adipose Tissue Differentiation
Context: Women with polycystic ovary syndrome (PCOS) and PCOS animal models have diminished brown adipose tissue (BAT) activity, potentially contributing to metabolic dysfunction. Besides classical androgens, adrenal 11-oxygenated androgens are elevated in women with PCOS. However, it remains unknown whether these 11-oxygenated androgens affect BAT metabolism. Objective: To study the effects of 11-ketotestosterone (KT) and 11-ketodihydrotestosterone (KDHT) on BAT metabolism. Methods: The female mouse brown adipocyte cell line T37i was treated with increasing concentrations (0.1-10 µM) of testosterone (T), dihydrotestosterone (DHT), KT, or KDHT during or after differentiation. In addition, female mice received a daily injection of vehicle, DHT, KT, or KDHT (100 µg) for 1 day or 1 week. Adipose depots were collected for RNA sequencing (RNAseq) analysis and Gene Set Enrichment Analysis (GSEA). Results: During differentiation, T, KT, DHT, and KDHT treatment of T37i cells dose-dependently reduced lipid droplet accumulation, and downregulated mRNA expression of adipogenic markers by up to 50%, with KDHT having the weakest effect. In mature T37i cells, only the high concentrations of these androgens exhibited inhibitory effects. RNAseq analysis revealed that DHT exposure induced the most differentially regulated genes in BAT, followed by KT and KDHT treatment. GSEA indicated that 1-day treatment with DHT and KT, but not KDHT, resulted in the downregulation of metabolic pathways in BAT. Conclusion: 11-Oxygenated androgens at high concentrations directly inhibit brown adipocyte differentiation in vitro and KT acutely downregulates BAT metabolic transcriptome in vivo, a result not observed with KDHT. These findings suggest that elevated 11-oxygenated androgens may impair BAT function, contributing to metabolic complications associated with hyperandrogenic conditions, including PCOS.
- 6 November 2025
- Published by The Endocrine Society in Endocrinology
- Vol. 166 (12)
Open Access11- Oxygenated Androgens Inhibit Brown Adipose Tissue Differentiation
Context: Women with polycystic ovary syndrome (PCOS) and PCOS animal models have diminished brown adipose tissue (BAT) activity, potentially contributing to metabolic dysfunction. Besides classical androgens, adrenal 11-oxygenated androgens are elevated in women with PCOS. However, it remains unknown whether these 11-oxygenated androgens affect BAT metabolism. Objective: To study the effects of 11-ketotestosterone (KT) and 11-ketodihydrotestosterone (KDHT) on BAT metabolism. Methods: The female mouse brown adipocyte cell line T37i was treated with increasing concentrations (0.1-10 µM) of testosterone (T), dihydrotestosterone (DHT), KT, or KDHT during or after differentiation. In addition, female mice received a daily injection of vehicle, DHT, KT, or KDHT (100 µg) for 1 day or 1 week. Adipose depots were collected for RNA sequencing (RNAseq) analysis and Gene Set Enrichment Analysis (GSEA). Results: During differentiation, T, KT, DHT, and KDHT treatment of T37i cells dose-dependently reduced lipid droplet accumulation, and downregulated mRNA expression of adipogenic markers by up to 50%, with KDHT having the weakest effect. In mature T37i cells, only the high concentrations of these androgens exhibited inhibitory effects. RNAseq analysis revealed that DHT exposure induced the most differentially regulated genes in BAT, followed by KT and KDHT treatment. GSEA indicated that 1-day treatment with DHT and KT, but not KDHT, resulted in the downregulation of metabolic pathways in BAT. Conclusion: 11-Oxygenated androgens at high concentrations directly inhibit brown adipocyte differentiation in vitro and KT acutely downregulates BAT metabolic transcriptome in vivo, a result not observed with KDHT. These findings suggest that elevated 11-oxygenated androgens may impair BAT function, contributing to metabolic complications associated with hyperandrogenic conditions, including PCOS.
- Open Access
- 6 November 2025
- Published by Portland Press Ltd. in Clinical Science
- Vol. 139 (21) , 1321-1336
SUL-138 mitigates accelerated endothelial aging and protects the kidney
Vascular aging is marked by increased levels of reactive oxygen species in endothelial cells. Reactive oxygen species can, among others, be produced by dysfunctional mitochondria, contributing to acceleration of vascular aging by promoting DNA damage response and senescence. In the aged vasculature, impaired endothelial cell function causes decreased vasodilation, which may also have an impact on peripheral organs such as the kidney. The aim of this study was to investigate the effect of chronic treatment with SUL-138 (30 mg/kg/day), a novel mitochondrial protective compound, on DNA damage-prompted, accelerated endothelial aging and associated kidney dysfunction in mice. Endothelial-specific aging was induced by knock-out (KO) of DNA repair endonuclease Ercc1 in mice [endothelial-cell specific Ercc1 KO (EC-KO) mice]. We showed that impaired endothelium-dependent vasodilation and expression of DNA damage response markers in EC-KO mice were restored after the treatment with SUL-138. The underlying mechanism of improved vasodilation was an increase in endothelium-derived hyperpolarization (EDH). Endothelial-specific aging induced tubular injury, sodium wasting, and increased inflammatory markers in the kidney, which were normalized by the treatment with SUL-138. We conclude that accelerated endothelial aging adversely affects vascular function and causes kidney tubular injury. SUL-138 rescues endothelial aging, restores vasodilation by increasing EDH, and protects the kidney. Thus, preservation of mitochondrial function is a potential pharmacotherapeutic target in aging-related dysfunction provoked by the DNA damage response.
- 6 November 2025
- Published by Portland Press Ltd. in Clinical Science
- Vol. 139 (21) , 1321-1336
Open AccessSUL-138 mitigates accelerated endothelial aging and protects the kidney
Vascular aging is marked by increased levels of reactive oxygen species in endothelial cells. Reactive oxygen species can, among others, be produced by dysfunctional mitochondria, contributing to acceleration of vascular aging by promoting DNA damage response and senescence. In the aged vasculature, impaired endothelial cell function causes decreased vasodilation, which may also have an impact on peripheral organs such as the kidney. The aim of this study was to investigate the effect of chronic treatment with SUL-138 (30 mg/kg/day), a novel mitochondrial protective compound, on DNA damage-prompted, accelerated endothelial aging and associated kidney dysfunction in mice. Endothelial-specific aging was induced by knock-out (KO) of DNA repair endonuclease Ercc1 in mice [endothelial-cell specific Ercc1 KO (EC-KO) mice]. We showed that impaired endothelium-dependent vasodilation and expression of DNA damage response markers in EC-KO mice were restored after the treatment with SUL-138. The underlying mechanism of improved vasodilation was an increase in endothelium-derived hyperpolarization (EDH). Endothelial-specific aging induced tubular injury, sodium wasting, and increased inflammatory markers in the kidney, which were normalized by the treatment with SUL-138. We conclude that accelerated endothelial aging adversely affects vascular function and causes kidney tubular injury. SUL-138 rescues endothelial aging, restores vasodilation by increasing EDH, and protects the kidney. Thus, preservation of mitochondrial function is a potential pharmacotherapeutic target in aging-related dysfunction provoked by the DNA damage response.